Metagenomi (MGX) announced that Eric Bjerkholt, CFO of Mirum Pharmaceuticals (MIRM), will join Metagenomi’s Board of Directors, serving on Metagenomi’s Audit and Compensation committees, effective January 27, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGX:
- Metagenomi price target raised to $14 from $7 at H.C. Wainwright
- Metagenomi presents updated preclinical NHP data at ASH meeting
- Metagenomi presents updated preclinical data in Hemophilia A at ASH
- Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks
- Class Action Lawsuit Against Metagenomi Inc. (NASDAQ:MGX)
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue